test44
https://www.cytel.com/blog/maximizing-preclinical-knowledge-nature-az
April 3, 2018
By Esha Senchaudhuri In response to its R&D productivity from 2005 – 2010, AstraZeneca took the initiative in 2011 to..
Read article
test44
https://www.cytel.com/blog/webinar-replay-program-simulations
October 18, 2017
Cytel's new Trial Innovations Webinar Series provides a platform for the most promising new statistical approaches..
Read article
test44
https://www.cytel.com/blog/cost-of-pharma-development
April 5, 2016
Cost of pharmaceutical development and R&D productivity is an ongoing industry concern, consistently discussed in..
Read article
test44
https://www.cytel.com/blog/how-to-shorten-a-cardiovascular-outcome-trial-by-two-years
February 10, 2015
Cardiovascular outcome trials (CVOTs) have earned the reputation of being the untamable behemoths of the clinical..
Read article
test44
https://www.cytel.com/blog/keepitsimple
September 18, 2014
When designing clinical trials, many trial designers are advised to keep the trial simple. Prima facie, the keep it..
Read article
test44
https://www.cytel.com/blog/new-book-on-trial-design-investment-strategy-for-pharmaceuticals
September 2, 2014
As more clinical trials make use of adaptive designs, investors have come to realize that high quality trial designs..
Read article
